News + Filings Charts Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Shegog Todd
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/08/2023 |
4
| Shegog Todd (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns:
| Granted 36,700 options to buy
@ $11.7, valued at
$429.4k
|
|
10/14/2022 |
4
| Shegog Todd (SVP, CFO) has filed a Form 4 on Forma Therapeutics Holdings, Inc.
Txns:
| Unknown transaction of 56,143 shares
@ $0 Disposed/sold 153,528 options to buy
@ $5.05, valued at
$775.3k
Disposed/sold 11,689 options to buy
@ $5.05, valued at
$59k
Disposed/sold 116,890 options to buy
@ $5.43, valued at
$634.7k
Disposed/sold 70,134 options to buy
@ $20, valued at
$1.4M
Disposed/sold 50,250 options to buy
@ $38.61, valued at
$1.9M
Disposed/sold 50,000 options to buy
@ $9.86, valued at
$493k
|
|
06/09/2022 |
4
| Shegog Todd (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns:
| Granted 30,700 options to buy
@ $4.59, valued at
$140.9k
|
|
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/15/2021 |
4
| Shegog Todd (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns:
| Granted 22,500 options to buy
@ $8.45, valued at
$190.1k
|
|
03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2021 |
4
| Shegog Todd (Director) has filed a Form 4 on Cogent Biosciences, Inc.
Txns:
| Granted 37,500 options to buy
@ $8.59, valued at
$322.1k
|
|
06/22/2020 |
4
| Shegog Todd (SVP, CFO) has filed a Form 4 on Forma Therapeutics Holdings, Inc.,
Txns:
| Granted 70,134 options to buy
@ $20, valued at
$1.4M
|
|
03/06/2019 |
4
| Shegog Todd (See Remarks) has filed a Form 4 on SYNLOGIC, INC.
Txns:
| Granted 58,500 options to buy
@ $8.59, valued at
$502.5k
|
|
03/15/2018 |
4
| Shegog Todd (See Remarks) has filed a Form 4 on SYNLOGIC, INC.
Txns:
| Granted 48,000 options to buy
@ $9.95, valued at
$477.6k
|
|
|
|